2.72
price down icon1.81%   -0.05
pre-market  Pre-mercato:  2.74   0.02   +0.74%
loading
Precedente Chiudi:
$2.77
Aprire:
$2.78
Volume 24 ore:
836.94K
Relative Volume:
1.05
Capitalizzazione di mercato:
$610.20M
Reddito:
$596.48M
Utile/perdita netta:
$123.72M
Rapporto P/E:
4.9599
EPS:
0.5484
Flusso di cassa netto:
$106.59M
1 W Prestazione:
-6.53%
1M Prestazione:
-12.26%
6M Prestazione:
-8.42%
1 anno Prestazione:
-8.72%
Intervallo 1D:
Value
$2.705
$2.81
Intervallo di 1 settimana:
Value
$2.705
$3.33
Portata 52W:
Value
$2.215
$5.28

Curevac N V Stock (CVAC) Company Profile

Name
Nome
Curevac N V
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
1,100
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
CVAC's Discussions on Twitter

Confronta CVAC con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CVAC
Curevac N V
2.72 610.20M 596.48M 123.72M 106.59M 0.5484
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.74 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
617.00 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
567.09 34.59B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
255.76 33.10B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
271.04 29.15B 3.81B -644.79M -669.77M -6.24

Curevac N V Stock (CVAC) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-04-25 Downgrade Leerink Partners Outperform → Market Perform
2023-06-08 Iniziato SVB Securities Outperform
2023-01-19 Aggiornamento UBS Neutral → Buy
2023-01-09 Aggiornamento Jefferies Hold → Buy
2022-01-21 Downgrade BofA Securities Neutral → Underperform
2022-01-18 Iniziato JMP Securities Mkt Outperform
2021-10-22 Iniziato Deutsche Bank Hold
2021-06-17 Downgrade BofA Securities Buy → Neutral
2021-04-26 Ripresa Credit Suisse Underperform
2021-04-26 Iniziato Guggenheim Neutral
2020-12-10 Downgrade Credit Suisse Neutral → Underperform
2020-09-08 Iniziato BofA Securities Buy
2020-09-08 Iniziato Credit Suisse Neutral
2020-09-08 Iniziato Jefferies Hold
Mostra tutto

Curevac N V Borsa (CVAC) Ultime notizie

pulisher
Apr 01, 2025

CureVac (NASDAQ:CVAC) Stock Price Down 7.2%What's Next? - MarketBeat

Apr 01, 2025
pulisher
Mar 28, 2025

CureVac: Patent Win Notable, But Won't Answer More Fundamental Questions (NASDAQ:CVAC) - Seeking Alpha

Mar 28, 2025
pulisher
Mar 28, 2025

CureVac (CVAC) Stock Surges After Favorable Patent Ruling - Stocks Telegraph

Mar 28, 2025
pulisher
Mar 28, 2025

European Patent Office Rules Vaccine Developer CureVac's Amended Patent Valid, Stock Jumps - Benzinga

Mar 28, 2025
pulisher
Mar 28, 2025

Lululemon, General Motors and Apple fall premarket; CureVac gains By Investing.com - Investing.com Canada

Mar 28, 2025
pulisher
Mar 28, 2025

Lululemon, General Motors and Apple fall premarket; CureVac gains - Investing.com India

Mar 28, 2025
pulisher
Mar 28, 2025

CureVac, gold miners, Rocket Lab - TradingView

Mar 28, 2025
pulisher
Mar 28, 2025

CureVac Patent Validated in BioNTech Dispute, Infringement Hearing Set for July - Marketscreener.com

Mar 28, 2025
pulisher
Mar 28, 2025

PRTG Soars On Mesothelioma Data, NVNO Awaits FDA Decision, CureVac Jumps On Patent News - RTTNews

Mar 28, 2025
pulisher
Mar 27, 2025

CureVac’s amended patent upheld by European Patent Office By Investing.com - Investing.com South Africa

Mar 27, 2025
pulisher
Mar 27, 2025

European Patent Office declares CureVac mRNA patent valid - Marketscreener.com

Mar 27, 2025
pulisher
Mar 27, 2025

CureVac up 13% as court upholds validity of patent in BioNTech spat - Seeking Alpha

Mar 27, 2025
pulisher
Mar 27, 2025

CureVac’s amended patent upheld by European Patent Office - Investing.com

Mar 27, 2025
pulisher
Mar 27, 2025

CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE - Yahoo Finance

Mar 27, 2025
pulisher
Mar 27, 2025

CureVac N.V. (CVAC) Gets Positive Validity Decision In Suit Vs BioNTech (BNTX)Bloomberg - StreetInsider

Mar 27, 2025
pulisher
Mar 27, 2025

EQS-News: CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE - Sharewise

Mar 27, 2025
pulisher
Mar 22, 2025

Amundi Sells 54,048 Shares of CureVac (NASDAQ:CVAC) - Defense World

Mar 22, 2025
pulisher
Mar 15, 2025

CureVac Stock: Recovery Continues Despite Weekly Fluctuations - Sharewise

Mar 15, 2025
pulisher
Mar 10, 2025

CureVac N.V.'s (NASDAQ:CVAC) largest shareholders are individual investors with 38% ownership, private equity firms own 31% - Yahoo Finance UK

Mar 10, 2025
pulisher
Mar 03, 2025

CureVac's CVnCoV Phase 2b/3 Study Data Published in Preprints with The Lancet - ACCESS Newswire

Mar 03, 2025
pulisher
Feb 27, 2025

CureVac Appoints International Financial Expert Michael Brosnan to Supervisory Board - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 21, 2025

CureVac: The mid-term effect of pipeline pruning -February 21, 2025 at 08:16 am EST - Marketscreener.com

Feb 21, 2025
pulisher
Feb 20, 2025

Is CureVac N.V. (CVAC) the Best Get Rich Fast Stock to Buy Now? - Insider Monkey

Feb 20, 2025
pulisher
Feb 20, 2025

12 Best Get Rich Fast Stocks To Buy Now - Insider Monkey

Feb 20, 2025
pulisher
Feb 19, 2025

A History of Outperforming Analyst Forecasts and Beating the Odds: CureVac N.V (CVAC) - SETE News

Feb 19, 2025
pulisher
Feb 18, 2025

CureVac Earns Repeat Recognition by LexisNexis(R) as One of the World’s Top Innovators - ACCESS Newswire

Feb 18, 2025
pulisher
Feb 18, 2025

mRNA Pioneer CureVac Clinches Elite Innovation Status with 1,000-Patent Arsenal - StockTitan

Feb 18, 2025
pulisher
Feb 17, 2025

CureVac's SWOT analysis: mRNA pioneer's stock faces pivotal year in vaccine race - MSN

Feb 17, 2025
pulisher
Feb 17, 2025

CureVac Appoints Klaus Edvardsen as Chief Development Officer - ACCESS Newswire

Feb 17, 2025
pulisher
Feb 16, 2025

JMP Securities Reiterates “Market Outperform” Rating for CureVac (NASDAQ:CVAC) - Defense World

Feb 16, 2025
pulisher
Feb 14, 2025

CureVac (NASDAQ:CVAC) Shares Gap UpWhat's Next? - MarketBeat

Feb 14, 2025
pulisher
Feb 12, 2025

Deadly Bird Flu Strain Detected In Nevada Man: 4 Stocks To Watch (CORRECTED) - Benzinga

Feb 12, 2025
pulisher
Feb 10, 2025

Deadly Bird Flu Strain Detected In Nevada Man: 4 Stocks To Watch - Benzinga

Feb 10, 2025
pulisher
Feb 06, 2025

CureVac (NASDAQ:CVAC) Trading Down 5.8%Time to Sell? - MarketBeat

Feb 06, 2025
pulisher
Feb 04, 2025

Individual investors among CureVac N.V.'s (NASDAQ:CVAC) largest stockholders and were hit after last week's 6.1% price drop - Simply Wall St

Feb 04, 2025
pulisher
Feb 01, 2025

Moderna, CureVac, other vaccine stocks jump as new human bird-flu cases reported in U.S., Australia - MSN

Feb 01, 2025
pulisher
Feb 01, 2025

CureVac NV (FRA:5CV) Altman Z-Score : 3.43 (As of Feb. 01, 2025) - GuruFocus.com

Feb 01, 2025
pulisher
Feb 01, 2025

CureVac NV (FRA:5CV) Momentum Rank : 7 (As of Feb. 01, 2025) - GuruFocus.com

Feb 01, 2025
pulisher
Jan 27, 2025

CureVac to Present at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting - ACCESS Newswire

Jan 27, 2025
pulisher
Jan 27, 2025

CureVac (NASDAQ:CVAC) Shares Sold by Ballentine Partners LLC - Defense World

Jan 27, 2025
pulisher
Jan 26, 2025

CureVac Announces Financial Results for the Second Quarter and First Half of 2024 and Provides Business Update - ACCESS Newswire

Jan 26, 2025
pulisher
Jan 26, 2025

Brokers Offer Predictions for CureVac FY2025 Earnings - Defense World

Jan 26, 2025
pulisher
Jan 25, 2025

CureVac Announces Financial Results for the Second Quarter and First Half of 2023 and Provides Business Update - ACCESS Newswire

Jan 25, 2025
pulisher
Jan 25, 2025

22,946 Shares in CureVac (NASDAQ:CVAC) Bought by Barclays PLC - Defense World

Jan 25, 2025
pulisher
Jan 25, 2025

CureVac to Report Third Quarter and First Nine Months 2024 Financial Results and Business Update on November 12, 2024 - ACCESS Newswire

Jan 25, 2025
pulisher
Jan 24, 2025

CureVac Strengthens Leadership Team with Appointment of Seasoned Industry Executive Axel Sven Malkomes as Chief Financial Officer - ACCESS Newswire

Jan 24, 2025
pulisher
Jan 24, 2025

FY2025 EPS Estimates for CureVac Raised by Leerink Partnrs - MarketBeat

Jan 24, 2025
pulisher
Jan 23, 2025

Companies Like CureVac (NASDAQ:CVAC) Are In A Position To Invest In Growth - Yahoo Finance

Jan 23, 2025
pulisher
Jan 22, 2025

CureVac (NASDAQ:CVAC) Stock Price Down 3.7%What's Next? - MarketBeat

Jan 22, 2025
pulisher
Jan 19, 2025

CureVac Announces Financial Results for the First Quarter of 2023 and Provides Business Update - ACCESS Newswire

Jan 19, 2025
pulisher
Jan 17, 2025

CureVac (NASDAQ:CVAC) Shares Up 4.7%Should You Buy? - MarketBeat

Jan 17, 2025

Curevac N V Azioni (CVAC) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$67.94
price down icon 3.89%
$72.00
price down icon 5.62%
$31.17
price up icon 0.13%
$18.80
price down icon 2.54%
$90.29
price down icon 0.85%
biotechnology ONC
$271.04
price down icon 0.42%
Capitalizzazione:     |  Volume (24 ore):